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Intracellular apoprotein B degradation is suppressed by decreased
albumin concentration in Rep G2 cells. It is generally accepted that
hepatic secretion of apoprotein (apo) B-containing lipoproteins is sub-
stantially increased in nephrosis. To elucidate the mechanisms for the
oversecretion of apo B, we investigated the effect of a various concentra-
tion of albumin on apo B kinetics in the absence or presence of oleate in
Hep G2 cells. Hep 02 cells were labeled with [3H]-leucine in leucine-free
medium containing 0, 1.5, 3.0 or 4.5% BSA for 180 minutes, and the
secreted radiolabeled apo B, apo Al and albumin were isolated by
immunoprecipitation and counted. The secretions of apo B and albumin
were suppressed by BSA (bovine serum albumin) in a dose-dependent
manner, but the secretion of apo Al was not suppressed significantly.
Oleate (0.4 mM) increased the rate of apo B secretion by 2.5-fold when
oleate was bound to 1.5% BSA, but at higher concentrations of BSA (3.0
or 4,5%), apo B secretion was less responsive to oleate. A pulse-chase
study indicated that early apo B degradation was significantly suppressed
in cells incubated with lower concentrations of BSA (0 or 1.5% BSA),
thereby rapidly stimulating apo B secretion. Oleate (0.4 mM) potently
inhibited apo B degradation when oleate was bound to 1.5% BSA,
whereas the inhibition was not observed when oleate was bound to 4.5%
BSA. Intracellular albumin synthesis was stimulated in BSA-free medium,
but intracellular decay of albumin was essentially unaffected by concen-
tration of BSA. Similar to BSA, a higher concentration of dextran (3.0 or
4.5%) reduced apo B secretion, and this was the result of increased early
apo B degradation in the cells. These results indicate that reduced albumin
suppresses intracellular apo B degradation, and the inhibition of apo B
degradation by oleate is manifested only at a low concentration of
albumin. Therefore, the present study suggests that free fatty acids bound
to low concentration of albumin in the circulating plasma play an
important role on hepatic oversecretion of apo B-containing lipoprotein in
hypoalbuminemic state, such as nephrotic syndrome.
Hyperlipidemia is a striking feature of nephrotic syndrome
[1—9] and characterized by elevations of plasma apoprotein (apo)
B-containing lipoproteins, and increased concentrations of these
lipoproteins have been implicated as risk factors for the develop-
ment of atherosclerosis in nephrotic patients [8, 9]. Pathogenesis
of elevation in apo B-containing lipoprotein in nephrotic syn-
drome is multifactorial; however, it is generally accepted that
hepatic production of these lipoproteins is substantially increased
in nephrosis [2, 7, 10, 11]. The exact mechanisms of the overpro-
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duction of the lipoproteins have not been well elucidated, but it
has been postulated that hepatic synthesis and secretion of
albumin are stimulated to compensate the urinary loss of albumin,
and the increased albumin biosynthesis leads to an increase in the
synthesis of lipoproteins because they share a common pathway
for synthesis and secretion [10, 11]. Despite this reasonable
explanation, many investigators have been unable to demonstrate
a correlation between the rate of synthesis of albumin and
lipoproteins [12—14] Kaysen et al [14] recently reported that
nephrotic patients showed normal albumin secretion rate al-
though they showed severe hyperlipidemia and hypoalbuminemia,
and thus concluded that no clear link can be established between
hyperlipidemia and the rate of albumin synthesis. Several exper-
imental studies indicated that decreased plasma oncotic pressure
and/or viscosity, rather than a low plasma albumin concentration
itself, play a primary role in stimulating very-low density lipopro-
tein (VLDL) secretion by the liver [5, 15, 16], suggesting that
overproduction of lipoprotein is not totally dependent upon
increased albumin synthesis in the nephrotic liver.
Most of the free fatty acids are bound to albumin in plasma
circulation. Although concentration of plasma albumin is mark-
edly decreased, circulating free fatty acid level is not significantly
changed in nephrotic patients or animals [17, 18], thus, free fatty
acids are relatively increased on its binding protein, albumin. The
role of fatty acids as modulators of hepatic apo B secretion have
been extensively studied utilizing Hep G2 cells, a human hepa-
toma cell line, and the results of these studies consistently
demonstrated that the addition of 0.4 to 0.8 mtvi oleate (corre-
sponds to physiological concentration of plasma free fatty acids)
to Hep G2 cells caused a several-fold increase in the apo B
secretion into the medium [19—23]. Dixon, Furukawa and 3ins-
berg [20] have reported that oleate rapidly increased apoB
secretion by suppressing early intracellular degradation of nascent
apoB in Hep G2 cells. However, in this study, oleate was
complexed with a low concentration of bovine serum albumin
(BSA) (1.5%), which is not physiological concentration of plasma
albumin, but rather corresponds to those of patients with ne-
phrotic syndrome. Scott and co-workers [19, 21] observed that
oleate increases apo B secretion, whereas Craig, Nutik and
Cooper [241 failed to observe the stimulatory effect of oleate in
Hep G2 cells. Both authors used the same concentration of oleate
(0.8 mM); however, the former used 3% BSA whereas the latter
used 5% BSA to make the oleate-albumin complex. These results
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led us to hypothesize that the stimulatory effect of oleate on apo
B secretion is manifested only in a low albumin concentration and
is suppressed by increased concentration of albumin. In the
present study, we studied intracellular kinetics of apo B and
albumin in Hep G2 cells incubated with a various concentration of
BSA (0, 1.5, 3.0 or 4.5%) in the presence or absence of oleate, to
determine the mechanisms of oversecretion of apo B and the
linkage of apo B and albumin kinetics in the liver of nephrotic
syndrome.
Methods
Materials
L-[4,5-3H]-leucine (catalog no. TRK 683) was purchased from
Amersham Corp. (Arlington Heights, IL, USA). Monospecific
anti-human apo B and apo Al antibodies were obtained from
Flow Laboratories (catalog no. AHP214; Helsinki, Finland).
Monospecific anti-human albumin was obtained from Cappel
(catalog no 55110, Malvern, PA, USA). Protein A-Sepharose
CL-4B was obtained from Pharmacia LKB Biotechnology Inc.
(Uppsala, Sweden). Minimum essential medium, non-essential
amino acids (catalog no. 320-1140), sodium pyruvate, penicillin!
streptomycin, leucine-free minimum essential medium (catalog
no. 320-1890AJ) and fetal bovine serum were purchased from
Gibco Laboratories (Grand Island, NY, USA). Leupeptin and
pepstatin A were obtained from Peninsula Laboratories, Inc.
(Belmont, CA, USA). Bovine serum albumin (BSA) (essential
fatty acid-free) and oleic acid (sodium salt) (catalog No. 0-7501)
were obtained from Sigma Chemical Co. (St. Louis, MO, USA),
and dextran (molecular wt 60,000 to 90,000) were obtained from
Wako Pure Chemical Industries (Osaka, Japan). Cellular protein
was determined by the commercially available kit using the
biocinchonic acid method (Pierce Chemical Co.).
Growth of Hep G2 cells
Hep G2 cells (ATCC, Rockville, MD, USA) were grown in
Falcon tissue culture dishes. Hep G2 cells were seeded into dishes
(4.5 X l0!100 mm dish or 1.1 >< 10!35 mm dish) and grown in
minimum essential medium supplemented with 10% fetal bovine
serum and 0.1 mM non-essential amino acids, 1 m sodium
pyruvate, penicillin/streptomycin (10,000 U/mi, complete medi-
um). After four days of growth, when the cells had reached 80%
confluency, the medium was changed to a serum-free experimen-
tal medium, and the experiments were initiated.
Apo B, apo Al and albumin secretion into the medium
Hep G2 cells were grown in 100 mm dishes. Hep G2 cells were
washed twice with phosphate-buffered saline (PBS) and incubated
in 10 ml of labeling medium (50 Ci of [3H]-leucine!ml in
leucine-free medium) containing 0, 1.5, 3.0, 4.5% BSA with or
without 0.4 mM oleate up to 180 minutes. Preparation of oleate!
albumin complex (oleate/BSA, mol!mol, ratios are 0.6, 0.9, 1.8,
respectively) were prepared as described previously [20]. In a
second experiment, the cells were incubated with labeling medium
in the presence of 0, 1.5, 3.0 and 4.5% dextran instead of BSA. At
the time indicated, 0.7 ml of medium was removed from each dish
and replaced with 0.7 ml of the appropriate fresh [3H]-leucine-
containing medium. An aliquot of medium (0.5 ml) was used to
measure the radioactivity of [3H]-apo B, and each 0.1 ml of
medium was used to measure the radioactivities of apo Al or
albumin, respectively. The medium containing secreted proteins
was transferred to tubes containing protease inhibitors (final
concentrations: 1 mM benzamidine, 5 mrvi EDTA, 0.86 m'vi phe-
nylmethylsulfonyl fluoride, 100 kallilrein-inactivating U/mi of
aprotinin, and 10 mrvt Hepes, pH 8.0). Immunoprecipitation of
[3H]-apo B, -apo Al or -albumin was carried out according to the
method described previously [20]. Briefly, aliquots of medium
were combined with 500 p1 or 900 tl of NET buffer (150 m
NaCI, 5 mrvt EDTA, and 50 mM Tris, pH 7.4, 0.5% Triton X-100,
and 0.1% SDS) and excess monospecific antihuman apoB, apo
Al, or albumin anti-serum and incubated overnight at 4°C on a
rocking platform. The next morning, 100 1.d of a 5% solution of
protein A-Sepharose CL-4B beads five times with 1 ml of NET
buffer, 100 p1 of electrophoresis buffer (0.125 M Tris-HC1, pH 6.8,
4% SDS, 20% glycerol, and 10% 2-mercaptoethanol) were added,
and apo B, apo Al or albumin were removed from the beads by
placing the microtube in a boiling water bath for five minutes. The
tube was centrifuged and the supernatant (25 p1) was taken for
scintillation counting. The rabbit antibody against human albumin
using the present study did not cross-react with BSA.
Pulse-chase studies for intracellular apo B and albumin kinetics
Hep G2 cells were grown in 35 mm dishes. Hep G2 cells were
washed twice with phosphate-buffered saline (PBS) and preincu-
bated in 1 ml of serum-free medium containing 0, 1.5, 3.0, 4.5%
BSA for 120 minutes. In the second experiment, the cells were
preincubated the medium containing 1.5 or 4.5% of BSA with or
without 0.4 mrvt oleate for 120 minutes. In the third experiment,
the cells were preincubated with the medium containing 0, 1.5, 3.0
or 4.5% dextran for 120 minutes. The media were then removed,
the cells were washed again twice with PBS and replaced in
leucine-free medium (1 ml) containing 100 Ci of [3H]-leucine.
After a 10 minute pulse, labeling medium was removed, the cells
were washed with PBS twice, and serum-free chase medium (1 ml)
was added. Pulse and chase media contained the same concen-
trations of each compound as the preincubation media. After
completion of chase periods, the cells were solubilized by adding
ice-cold lysis buffer (150 m NaCl, 5 mrvi EDTA, 50 mrvi Tris, pH
7.4, 0.0625 M sucrose, 0.5% Triton X-lOO, 0.5% sodium deoxy-
cholate containing 0.05 mg/mi leupeptin and 0.05 mg/ml pepstan
A) in addition to the protease inhibitor mixture, and incubated
overnight at 4°C on a rocking platform. The next morning,
aliquots (0.5 ml) of the cell extract supernatants or chase-medium
were taken for apo B, or albumin immunoprecipitation by the
same method described above.
In the preliminary experiments, we confirmed that the immu-
noprecipitated apo B, albumin or apo Al in the cell extracts or the
medium ran as a single band on 3 to 15% SDS-poiyacrylamide gel
electrophoresis (SDS-PAGE) and autoradiography [20], with
minimal degradation. Therefore, in the present study, we did not
measure the count of specific protein bands electrophoresed by
SDS-PAGE but counted the immunoprecipitated proteins di-
rectly.
Analysis of variance (ANOVA) was used to determine statisti-
cal significance and P < 0.05 was accepted as statistical signifi-
cance.
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Fig. 1. Effect of a various concentration of BSA in the presence or absence
of oleate on apo B secretion. A, Effect of BSA on secretion of apo B into the
medium. Hep G2 cells were washed with PBS and incubated in 10 ml of
labeling medium (50 Ci of [3H]-leucine/ml) in the absence of BSA (El;
—) or in the presence of 1.5 (•), 3.0 (U), or 4.5% (K') BSA. At the times •
indicated, 0.5 ml of medium was removed from each dish and replaced
with 0.5 ml of the appropriate fresh [3H]-leucine-containing medium. Apo
B was immunoprecipitated from the medium as described in the Methods.
B. Effect of oleate bound to a various concentration of BSA on apo B
secretion. Oleate (0.4 mM) was bound to 1.5 (•), 3.0 (U), or 4.5% (K')
BSA. Data represent mean SEM of 4 experiments. A vs. BSA (—), Bvs. x
BSA (1.5%). P < 0.05 by ANOVA. C. Cpm/mg cell protein for 0.4 mM
oleate-albumin (U, 1.5; , 3.0; or , 4.5%) complex were devided by that
obtained from cells incubated with identical concentration of BSA alone
to obtain the relative change in the secretion of [3H]-apo B. a
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the BSA concentration in medium. Therefore, the values from the
10-minutes chase time point were taken as 100%, and the cellular
content of radiolabeled apoB was monitored over an additional 50
minutes of chase (Table 1). When the Hep G2 cells were pulsed
and chased in the absence or presence of various concentrations
a
Results
Effect of BSA on secretion of apo B into the medium
Apo B secretion was examined in the cells incubated with a
various concentration of BSA (0 to 4.5% (wt/vol). The radioac-
tivity of apo B in the medium increased linearly with time up to
180 minutes in all treatments (Fig. 1A). BSA inhibited apo B
secretion in a dose-dependent manner. The inhibition was ob-
served at the earliest time point measured (60 mm) and persisted
during the 180-minute incubation period. Hep G2 cells cultured
for 180 minutes in serum-free medium supplemented with 1.5, 3.0
or 4.5% BSA (wt/vol) decreased [3H]-apo B secretion into the
culture medium by 30, 44 and 60%, respectively, compared to cells
cultured in serum-free medium alone [BSA(—)].
Effect of oleate on apo B secretion in a various concentration of
BSA
The effect of varying doses of BSA on the rates of apo B
secretion in the presence of oleate (0.4 mM) is shown in Figure lB
and compared with those from cells incubated with identical
concentration of BSA alone (Fig. IC). Supplementation of the
culture medium with oleate-1.5% albumin complex increased apo
B secretion on average by 2.5-fold compared to the cells incubated
with 1.5% BSA alone (Figure 1C). The oleate-induced stimula-
tion of apo B secretion was marked diminished when oleate was
bound to higher concentration of BSA (3.0 or 4.5%). At the
180-minute incubation period, these oleate-albumin complex in-
creased apo B secretion only by 1.2- to 1.4-fold compared to those
from cells incubated with identical BSA alone.
A pulse-chase study for intracellular apo B degradation and
secretion
Intracellular apo B degradation in Hep G2 cells was examined
in the absence or presence of a various concentration of BSA (Fig.
2 and Table 1). We previously reported that when Hep G2 cells
were pulsed with [3H]-leucine for 10 minutes and then chased for
10 minutes, the cellular radioactivity of apo B represented nascent
apo B production [201. A similar amount of labeled apo B was
present in the absence or presence of 1.5 or 3.0% BSA after 10
minutes of chase (Fig. 2A). The highest concentration of BSA
(4.5%) tended to suppress apo B production, but this figure did
not attain statistical significance (Fig. 2A), and thus we concluded
that apo B production in the cells was not significantly affected by
a
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Table 1. Analysis of intracellular [3H]-apo B decay and secretion into
medium
% of initial [3H]-apo B synthesized
[3H]-apo B remaining [3H1-apo B secreted
N in the cells N into medium
Time of chase mm
Treatment 30 60 30 60
BSA(—) 7 71.5 4.5 45.0 4.2 6 10.5 0.1 41.1 3.3
1.5% BSA 16 62.3 5.3 31.5 2.6 6 5.5 0.0 24.2 3.4
3.0% BSA 11 48.8 2.7 25.3 2.3 6 4.0 0.0 21.6 1.5
4.5% BSA 5 47.6 3.5 22.5 5.5 6 3.9 0.1 22.2 1.7
Hep G2 cells were pretreated with serum-free medium in the absence
[BSA(—)] or in the presence of 1.5, 3.0 or 4.5% BSA for 2 hours, then
pulsed with 100 Ci of F3H]-leucine/ml for 10 mm and then chased for 10,
30 and 60 mm with serum-free medium containing the same concentration
of BSA as the respective preincubation media. The radioactivities of
[3H]-apo B immunoprecipitated from each time point were divided by the
respective radioactivity of [3H]-apo B mmunoprecipitated from cells that
had been chased for 10 mm (taken as 100%). The data are presented as
percent of the initial apo B synthesized, and the values represent the mean
SEM of number (N) of experiments.
of BSA, intracellular decay of {3H]-apo B was increased progres-
sively with increasing concentration of BSA. At the 30 minute
chase, approximately 50% of nascent apo B was decayed in 3.0 or
4.5% BSA-treated cells, whereas 71 or 62% of initial apo B still
remained in non-BSA treated or 1.5% BSA-treated cells, respec-
tively. At 60 minutes of chase, 70 to 75% of the initial apo B was
decayed in 1.5, 3.0 or 4.5% BSA-treated cells, but still less of apo
B was decayed in cells without BSA. It has been reported that
newly synthesized apo B is rapidly (within 30 mm) degraded in
early secretory pathway, and a considerable amount of initially
synthetized apo B is not secreted into the medium but degraded
intracellulary [20—23, 25]. In agreement with previous reports [20,
22], only a small amount of radiolabeled apo B appeared in the
culture medium at 30 minutes into the chase, and apo B secretion
into the medium was then increased during the next 30-minute
chase period (Fig. 2B). However, a considerable amount of
[3H]-apo B had already appeared in the medium at the 30 minute
chase, and a much higher amount of apo B was secreted during
the next 30-minute chase period in cells incubated with BSA-free
medium (Fig. 2B). Apo B secretion in the chase medium was
suppressed by BSA in a dose-dependent manner, although the
dose dependency was less apparent than that observed in the long
pulse (180 mm) study shown in Figure 1. The total radioactivity
recovered in the cells and medium was 44 to 56% in BSA-treated
cells during the 60-minute chase period, whereas 86% of initially
synthesized apo B was recovered in the cells and medium when
cells were incubated in the absence of BSA (Table 1). This
indicated that apo B degradation was substantially suppressed,
thereby stimulating apo B secretion in the cells incubated with
BSA-free medium.
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Fig. 2. Intracellular degradation of [3H]-apo B (A) and secretion into chase medium (B). Hep G2 cells were pretreated with serum-free medium in the
absence of BSA (El; —) or in the presence of 1.5 (•), 3.0 (U), or 4.5% (SO')BSA for 2 hours, then pulsed with 100 Ci of [3H]-leucine/ml for 10 mm
and then chased for 10, 30 and 60 mm with serum-free medium containing the same concentration of BSA as the respective preincubaton media. The
cells were solubilized with a lysis buffer, and [3H]-apo B in the cell extract or medium was immunoprecipitated as described in the Methods section. Each
point indicates the mean SEM of the number (N) of experiments. A vs. BSA (—), B vs. BSA (1.5%), C vs. BSA (3.0%), P < 0.05 by ANOVA.
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Effect of oleate on apo B degradation and secretion in the
presence of either low or high concentration of BSA
As indicated in Figure 1C, oleate potently stimulated apo B
secretion when oleate was bound to 1.5% BSA, but the effect was
sluggish when oleate was bound to higher concentrations of BSA
(3.5, or 4.5%). To explore this finding, we conducted a pulse-chase
study to compare the effect of oleate on intracellular apo B
kinetics in the presence of low (1.5%) or high (4.5%) concentra-
tion of BSA. Oleate bound to 1.5% BSA inhibited intracellular
apo B degradation (Fig. 3A), thereby increasing apo B secretion
into the medium (Fig. 3B), which was consistent with our earlier
work [20, 22]. In contrast, oleate failed to inhibit apo B degrada-
tion (Fig. 3A), so that apo B secretion into chase medium was not
increased (Fig. 3B) when oleate was bound to 4.5% BSA.
Effect of dextran on apo B secretion and degradation
We observed that BSA suppressed apo B secretion by acceler-
ating intracellular apo B degradation in a dose-dependent manner
(Fig. 2, Table 1). To test whether the effect of BSA is attributable
to albumin per se or to the oncotic pressure and/or viscosity
resulting from the change in the BSA concentration, Hep G2 cells
were incubated with 0, 1.5, 3.0 or 4.5% dextran instead of BSA.
Addition of higher concentrations of dextran (3.0 or 4.5%) to the
medium suppressed apo B secretion, although the suppression by
dextran was somewhat weaker than that of BSA (Fig. 4A). Apo B
secretion after 180 minutes of incubation was decreased by 13, 32
and 51% by 1.5, 3.0 and 4.5% dextran (wt/vol), respectively,
compared to when the cells were cultured in serum-free medium
alone [dextran(—)]. In accord with this suppressive effect of
dextran on apo B secretion, a pulse-chase study revealed that
higher concentrations of dextran (3.0 or 4.5%) significantly accel-
erated early apo B degradation (during the 10 to 30 mm chase
period) in cells (Fig. 4B), and thereby inhibited early apo B
secretion into the chase medium (Fig. 4C).
Effect of BSA on secretion and intracellular decay of albumin
The radioactivity of [3H]-albumin was linearly increased into
medium up to 180 minutes in all incubations, and the secretion
was suppressed by BSA in a concentration-dependent manner
(Fig. 5A). Oleate did not affect the rate of albumin secretion
regardless of BSA concentrations (Fig. SB). Dixon, Furukawa and
Ginsberg reported [20] that when Hep G2 cells were pulsed with
[3H]-leucine for 10 minutes and then chased for 10 minutes, the
cellular radioactivity of albumin represented albumin production.
A pulse-chase study demonstrated that the radioactivity of albu-
min at 10-minute chase period was significantly higher in the
absence of BSA compared with those in BSA-treated cells (Fig.
6A), indicating albumin production is increased in the absence of
BSA. However, when the values from the 10-minute chase time
point were taken as 100%, and the cellular content of radiolabeled
albumin was monitored over an additional 50 minutes of chase,
BSA did not affect intracellular decay of albumin (Table 2). The
pattern of intracellular decay of albumin and secretion into
medium was quite different from those of apo B. Over 20% of the
newly synthesized albumin was already secreted during the 30
minutes chase and the newly synthesized albumin was completely
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Fig. 3. Effect of oleate on intracellular degradation of [3H]-apo B (A) and secretion into chase medium (B) in the presence of a low or a high concentration
of BSA. Hep G2 cells were pretreated with serum-free medium containing 1.5 or 4.5% BSA in the absence or presence of 0.4 mrvi oleate for 2 hours,
then pulsed with 0.1 mCi of [3H]-leucine/ml for 10 mm and then chased for 10, 30 and 60 mm with serum-free medium containing the same
concentration of BSA or the oleate-BSA complex as the respective preincubaton media. Each point indicates the mean SEM of four experiments. A
vs. BSA (1,5%), P < 0.05 by ANOVA. Symbols are: (0) BSA 1.5%; (•) BSA 1.5% + OA; (El) BSA 4.5%; (•) BSA 4.5% + OA.
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Fig. 4. Effect of various concentrations of
dextran on apo B secretion and intracellular apo
B degradation. Effect of dextran on secretion of
apo B into the medium (A). Hep G2 cells were
washed with PBS and incubated in 10 ml of
labeling medium (35 xCi of [3H]-leucine/ml) in
the absence of dextran (,
—) or presence of
1.5 (•), 3.0 (U), or 4.5% (K') dextran. At the
times indicated, 0.5 ml of medium was removed
from each dish and replaced with 0.5 ml of the
appropriate fresh [3H]-leucine-containing
medium. Apo B was immunoprecipitated from
the medium as described in the Methods. Effect
of various concentrations of dextran on
intracellular degradation of [3H]-apo B (B) and
secretion into chase medium (C). Hep G2 cells
were pretreated with serum-free medium in the
absence [dextran (—)] or presence of 1.5, 3.0 or
4.5% dextran for 2 hours, pulsed with 100 xCi
of [3H}-leucine/ml for 10 mm and then chased
for 10, 30 and 60 minutes with serum-free
medium containing the same concentration of
dextran as in the respective preincubation
medium. Each point indicates the mean SEM
of three experiments. A vs. dextran (—); B vs.
1.5% dextran; P < 0.05 by ANOVA.
recovered into the medium during 60-minute chase period (Table
2). The secretion of albumin into the chase media was significantly
increased in the absence of BSA and was suppressed in the
presence of BSA (Fig. 6B), which is in agreement with the results
showing that intracellular albumin production is increased and the
increased albumin is entirely secreted into chase medium (Fig.
6A, Table 2).
Effect of BSA or oleate on apo Al secretion
The radioactivity of [3H]-apo Al was linearly increased into
medium up to 180 minutes in all incubations. In contrast to apo B
or albumin, the secretion of apo Al was not significantly sup-
pressed by BSA (Fig. 7A). Unlike apo B, supplementation of the
culture medium with 0.4 m'vi oleate bound to 1.5, 3.0 or 4.5% BSA
did not increase apo Al secretion, compared to those of the
identical concentration of BSA alone (Fig. 7B).
Discussion
Most recent works indicate that the modification in apo B
synthesis observed in response to various mediators [19] or in
physiological situation [26] has never been related to the amount
of apo B mRNA abundance although apo B secretion was
significantly influenced by these modifications. In other words,
apo B gene is constitutively expressed in hepatocytes and the
mechanism of acute regulation of apo B production by these cells
must involve post-translational processes [19, 23]. Pullinger et al
[19] reported that when Hep G2 cells were incubated with a
various concentration of BSA, apo B secretion was suppressed in
a concentration-dependent manner, but any changes in apo B
mRNA levels was not observed, suggesting that post-translational
mechanisms are responsible for the reduction in the rate of apo B
output by BSA. It has become obvious that a large fraction of apo
B synthesized is quickly degraded early in the secretory pathway in
hepatocytes [20, 23, 25], and several studies indicated that hor-
mones or lipids, such as insulin [27], free fatty acids [20, 28], or
LDL [25] which strongly affect apo B secretion, can alter the rate
of apo B degradation in hepatocytes, thereby critically regulating
apo B secretion. We therefore speculated that albumin as well as
these substances affects intracellular apo B degradation in hepa-
tocytes and this regulates the rate of apo B secretion into medium.
Similar to previous reports by others [19, 29], the present study
demonstrated that apo B secretion was suppressed by BSA in a
dose-dependent manner. Furthermore, we found that the influ-
ence of BSA upon apo B secretion quickly appeared; higher
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Fig. 5. Effect of various concentrations of BSA in the presence or absence of oleate on albumin secretion. A. Effect of BSA on secretion of apo B into the
medium. Hep 02 cells were washed with PBS and incubated in 10 ml of labeling medium (50 txCi of [3H]-leucine/ml) in the absence of BSA (0; —)
or in the presence of 1.5 (•), 3.0 (a), or 4.5% (0) BSA (wt/vol). At the times indicated, 0.1 ml of medium was removed from each dish and replaced
with 0.1 ml of the appropriate fresh [3H]-leucine-containing medium. [3H]-albumin was immunoprecipitated from the medium as described in the
Methods. Each point indicates the mean 5EM of four experiments. A vs. BSA (—), Bvs. BSA (1.5%), P < 0.05 by ANOVA. B. Effect of oleate bound
to a various concentration of BSA on albumin secretion. Cpm/mg cell protein for 0.4 mrvi oleate-albumin (a, 1.5; , 3.0; or , 4.5%) complex were
divided by that obtained from cells incubated with identical concentration of BSA alone to obtain the relative change in the secretion of [3H]-albumin.
concentration of BSA suppressed apo B secretion as early as
60-minute incubation period. Considering that a half-life of apo B
mRNA in Hep 02 cells is about 16 hours [19], it is unlikely that
the rapid suppression of apo B output by BSA is related to reduce
apo B mRNA in the cells. In fact, a pulse-chase study revealed
that initial synthetized apo B production was not significantly
altered, but the rate of intracellular apo B degradation was
strongly affected by BSA. We could not rule out the possibility
that apo B synthesis is decreased by high BSA concentrations
because there may be lower synthesis at 4.5% BSA (Fig. 2), and in
the present study we did not measure the abundance of apo B
mRNA in cells treated with various concentrations of BSA.
However, because we have established that the 10 minute pulse 10
minute chase protocol gives a fairly good estimate of apo B
synthesis [20], the data in Figure 2 may indicate fairly conclusively
that 0, 1.5 and 3.0% BSA exert a minimal effect on apo B
synthesis. Hara, McCall and Forte [30] demonstrated that re-
uptake of nascent low-density lipoprotein is quantitatively insig-
nificant in Hep 02 cells. In addition, the incubation period in the
present study is very short (only within 180 mm). Therefore, it is
unlikely that the present data are affected by the uptake of
newly-secreted lipoproteins from Hep 02 cells. We concluded
that intracellular apo B degradation is mainly responsible for the
post-translational event which critically regulates apo B secretion
in the case of albumin as well as other substances.
The recent studies [23, 25, 3 1—33] suggest that the site of early
apo B degradation occurred in ER before translocating to Golgi
apparatus. Furukawa et al [33] found that isolated ER contained
a proteolytic activity which degrades apo B, whereas Golgi did not
in Hep 02 cells. It remains to be investigated whether the
chemical structure or physiological nature of the putative protease
(or proteases) is responsible for apo B degradation. Interestingly,
Sato et al [25] demonstrated that the early apo B degradation was
completely suppressed when Hep 02 cells were incubated in a low
temperature (below 20°C), suggesting that proteolytic activity for
apo B degradation could easily be inactivated by altered physio-
logical conditions surrounding the cells. Therefore, we hypothe-
sized that the putative protease which degrades apo B can be
inactivated by a reduction in the oncotic pressure and/or viscosity
resulting from a reduced albumin concentration. Indeed, apo B
degradation was significantly suppressed in the macromolecule-
free medium. The suppressive effect of dextran on the secretion
was weaker than that of BSA. This is consistent with the result of
Pullinger et al [19], who showed that the suppression of apo B
secretion by 3% dextran or 3% ovalbumin was only half of that by
3% BSA. This corresponds to the weak modulations of apo B
secretion and decay by dextran observed in the pulse-chase study.
Therefore, we cannot conclude that the significant effect of BSA
on apo B kinetics is simply because of a change in the oncotic
pressure and/or viscosity. In preliminary studies, we examined the
effect of dextran on the albumin and apo Al kinetics. However,
we could not get any consistent results indicating that the effect of
dextran is specific for apo B kinetics. Nevertheless, there is no
doubt that oncotic pressure and/or viscosity plays an important
role in the intracellular apo B kinetics in Hep 02 cells.
It has become apparent that oleate stimulates apo B secretion
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Fig. 6. Effect of BSA on intracellular albumin decay (A) and secretion (B). Hep G2 cells were pretreated with serum-free medium in the absence of BSA
(E; —) or presence of 1.5 (•), 3.0 (•), or 4.5% () BSA for 2 hours, then pulsed with 100 jCi of [3H]-leucine/ml for 10 mm and then chased for 10,
30 and 60 mm with serum-free medium containing the same concentration of BSA as the respective preincubaton media. Each point indicates the mean
SEM of eight experiments. A vs. BSA (—), P < 0.05 by ANOVA.
Table 2. Analysis of intracellular [3H]-albumin decay and secretion into
medium
% of initial [3H]-albumin synthesized
[3H}-albumin remaining [3H]-albumin secreted
N in the cells N into medium
Time of chase mm
Treatment 30 60 30 60
BSA (—) 6 64.5 12.9 21.8 5.2 6 20.2 4.7 99.9 9.8
1.5% BSA 6 83.6 7.8 21.7 3.0 6 21.9 3.8 98.6 6.0
3.0% BSA 6 72.1 2.4 18.2 4.3 6 19.8 2.8 114.8 12.6
4.5% BSA 6 79.5 5.3 20.4 0.7 6 27.1 2.2 96.4 8.3
Hep G2 cells were pretreated with serum-free medium in the absence
[BSA(—)] or in the presence of 1.5, 3.0 or 4.5% BSA for 2 hours, then
pulsed with 100 Ci of [3H]-leucine/ml for 10 mm and then chased for 10,
30 and 60 mm with serum-free medium containing the same concentration
of BSA as the respective preincubation media. The radioactivities of
[3H]-albumin immunoprecipitated from each time point were divided by
the respective radioactivity of [3Hj-albumin immunoprecipitated from
cells that had been chased for 10 mm (taken as 100%). The data are
presented as percent of the initial albumin synthesized, and the values
represent the mean SEM of number (N) of experiments.
in Hep G2 cells [19—23]. White et al [21] reported that, although
0.8 mivi oleate bound to 3.0% BSA stimulates apo B secretion, apo
B mRNA levels were not increased in Hep G2 cells. We have
reported that the potent stimulation of apo B secretion by 0.4 mM
oleate bound to 1.5% BSA could be observed as early as 30
minutes after the addition of oleate into the medium, and the
rapid stimulation of apoB secretion by the oleate-albumin com-
plex was not associated with an increase in apoB production but
with reduced early apo B degradation in Hep G2 cells [20, 221. It
has already been reported that increased molar ratio of oleate to
albumin stimulates the secretions of very-low density lipoprotein
(VLDL) or apo B from hepatocytes [15, 20]. However, in these
studies, concentration of oleate was varied without a change in
BSA concentration to make a different ratio of fatty acid-albumin
complex. Physiological level of albumin in normal human plasma
exceeds 3 g/dl, and thus 1.5% BSA used in earlier work [20, 22] is
not at a physiological level, but rather corresponds to the plasma
level of patients with the nephrotic syndrome. In the present
study, we examined the effect of oleate on apo B degradation and
secretion when 0.4 mrvt oleate was bound to a high concentration
of BSA (4.5%) and found that oleate-induced stimulation in apo
B secretion was significantly suppressed. A pulse-chase study
revealed that the apo B degradation was not reduced by oleate in
the presence of a high concentration of BSA. Although the exact
mechanisms for inhibiting apo B degradation by oleate are still
unknown, recent works suggest that the inhibition is associated
with changes in the composition of nascent apo B-containing
lipoproteins [23, 33]. Oleate rapidly and substantially increases
the triglyceride content in nascent apo B-containing lipoproteins
[20, 22, 33], and this triglyceride-enrichment may become a
protective barrier against intracellular proteolysis of apo B,
thereby facilitating transport of apo B out of a protease-contain-
ing compartment associated with ER. Davis et al [15] reported
that albumin or dextran did not affect intracellular triglyceride or
cholesterol synthesis. Therefore, it is unlikely that suppression of
apo B degradation under a low concentration of albumin is
associated with lipid-facilitated translocation of apo B. Furukawa
et al [33] demonstrated that the protective effect of oleate on apo
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Fig. 7. Effect of various concentrations of BSA in the presence or absence of oleate on apo Al secretion. A. Effect of BSA on secretion of apo Al into the
medium. Hep 02 cells were washed with PBS and incubated in 10 ml of labeling medium (50 gCi of [3H]-leucine/ml) in the absence of BSA (0; —)
or in the presence of 1.5 (•), 3.0 (•), or 4.5% (Ky) BSA. At the times indicated, 0.1 ml of medium was removed from each dish and replaced with 0.1
ml of the appropriate fresh [3H]-leucine-containing medium. [3H]-apo Al was immunoprecipitated from the medium as described in the Methods
sections. Each point indicates the mean SaM of four experiments. No significant difference was observed among different group of incubations by
ANOVA. B. Effect of oleate bound to a various concentration of BSA on apo Al secretion. Cpm/mg cell protein for 0.4 mtvi oleate-albumin (•, 1.5;
3.0; or , 4.5%) complex were divided by that obtained from cells incubated with identical concentration of BSA alone to obtain the relative change
in the secretion of [3H]-apo Al.
B degradation was abolished by treatment of Brefeldin A which
specifically blocks intracellular translocation from ER to the
Golgi, suggesting that oleate dose not suppress the proteolysis of
apo B degradation in ER. If the proteolytic activity is suppressed
by a decrease in albumin concentration, mechanisms of inhibiting
apo B degradation by oleate and a low albumin are different. It is
thus reasonable to observe that oleate and low albumin synergis-
tically inhibit apo B degradation and stimulate apo B secretion.
We speculate that under a low albumin concentration, the activity
of apo B protease is reduced and the lipid-facilitating apo B
transport by oleate can overcome the degradation by the low
proteolytic activity. Alternatively, under a high concentration of
BSA, the facilitaing apo B transport is not strong enough to
protect against apo B degradation by normal proteolytic activity.
The rate of albumin secretion by Hep 02 cells was significantly
increased in the absence of BSA and suppressed by BSA in a
dose-dependent manner. Although BSA suppresses both secre-
tions of apo B and albumin, the mechanism was different in each
case. Previous work [20] and the present study demonstrate that
initially synthesized albumin was not degraded during intracellu-
lar transport pathway but entirely secreted into medium. There-
fore, albumin secretion appeared to be totally dependent on the
initial production in the cells. A pulse-chase study revealed that
initial albumin production was significantly increased in cells
incubated with BSA-free medium. Although we failed to demon-
strate that the initial production of albumin was suppressed by
BSA in a dose-dependent manner, the present results still support
that the rate of albumin secretion is dependent upon the initial
production, because decay of intracellular [3H]-albumin was not
altered by BSA, and initially synthesized [3H]-albumin was totally
recovered into the medium without being degraded intracellulary.
Davis et al [15] reported that the secretion of VLDL triglyceride
or insoluble VLDL proteins (apo B) was substantially suppressed
by BAS or dextran, but other proteins (fraction of density >
1.006) containing albumin secreted by the cells were not sup-
pressed by these macromolecules. However, they did not measure
albumin secretion directly, and hence their data cannot eliminate
the possibility of the suppressive effect of BSA on albumin
secretion observed in the present study. Yamauchi et al [34] have
recently demonstrated that increased oncotic pressure by supple-
mentation of dextran rapidly (within 4 hr) and dose-dependently
suppressed albumin mRNA abundance in cultured rat hepatoma
cells. Their finding may support the present data showing that the
production and secretion of albumin are enhanced in the absence
of BSA and suppressed in the presence of BSA.
Marsh and Sparks [35] demonstrated that apo £ secretion was
increased by 1.8, apo B by 2.8 and apo Al by 8.4, whereas the
secretion of apo C was not significantly altered in perfused livers
of nephrotic rats. Boustani et al [36] reported that specific mRNA
levels of apo Al, apo £ and albumin were increased by 5, 2.4, and
1.7, whereas mRAN of apo B was not significantly altered in the
livers from nephrotic rats. Tarugi et al [37] also demonstrated that
although albumin mRNA was steadily increased during the whole
period of observation, apo B mRNA was only transiently in-
creased and decreased toward the normal levels with age in
spontaneous chronic progressive nephrotic rats. In the present
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study we demonstrated that BSA potently affect kinetics of apo B
but not that of Al. Therefore, the biosynthesis of apoproteins may
not be totally dependent upon albumin synthesis, and the synthe-
sis of apoproteins is differently regulated by each other. Sato et al
[25] demonstrated that a newly synthesized apo Al was not
degraded intracellulary but entialy secreted into the medium,
which is similar to albumin. Apo B and apo E [38] are degraded
intracellulary, but albumin and apo Al are not. The secretion of
apo B is mainly regulated by the rate of intracellular degradation,
whereas albumin or apo Al are regulated by the rate of intracel-
lular production. Even though the secretions of apo B and
albumin are enhanced in a low albumin concentration, the
mechanism of stimulation in the secretion of these proteins is
quite different. Therefore, it is not surprising that the rate of apo
B secretion is not always correlated with albumin synthesis.
In conclusion, the present study provides a new mechanism to
explain enhanced apo B secretion in the nephrotic syndrome. We
demonstrate that apo B secretion is significantly enhanced with
reduced albumin concentration, and this is not associated with
increased apo B synthesis, but with reduced intracellular apo B
degradation. Oleate potently stimulates apo B secretion by sup-
pressing apo B degradation only when oleate is bound to a low
albumin concentration. Therefore, the present study suggests that
free fatty acids bound to low concentration of albumin in the
circulating plasma play an important role on hepatic oversecretion
of apo B-containing lipoprotein in the nephrotic syndrome.
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